Canada · Delayed Price · Currency is CAD Restart Life Sciences Statistics
Total Valuation
CSE:HEAL has a market cap or net worth of CAD 4.36 million. The enterprise value is 3.53 million.
| Market Cap | 4.36M |
| Enterprise Value | 3.53M |
Important Dates
The next estimated earnings date is Tuesday, September 1, 2026.
| Earnings Date | Sep 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:HEAL has 62.36 million shares outstanding. The number of shares has increased by 126.34% in one year.
| Current Share Class | 62.36M |
| Shares Outstanding | 62.36M |
| Shares Change (YoY) | +126.34% |
| Shares Change (QoQ) | +43.85% |
| Owned by Insiders (%) | 8.46% |
| Owned by Institutions (%) | 0.73% |
| Float | 57.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.37 |
| PB Ratio | 3.29 |
| P/TBV Ratio | 8.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.85 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.63 |
| Interest Coverage | -85.48 |
Financial Efficiency
Return on equity (ROE) is -246.66% and return on invested capital (ROIC) is -126.14%.
| Return on Equity (ROE) | -246.66% |
| Return on Assets (ROA) | -100.38% |
| Return on Invested Capital (ROIC) | -126.14% |
| Return on Capital Employed (ROCE) | -131.49% |
| Weighted Average Cost of Capital (WACC) | 0.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.50% in the last 52 weeks. The beta is -0.81, so CSE:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | -0.81 |
| 52-Week Price Change | -12.50% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 40.10 |
| Average Volume (20 Days) | 71,440 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:HEAL had revenue of CAD 465,715 and -1.71 million in losses. Loss per share was -0.04.
| Revenue | 465,715 |
| Gross Profit | 192,636 |
| Operating Income | -1.75M |
| Pretax Income | -1.71M |
| Net Income | -1.71M |
| EBITDA | -1.74M |
| EBIT | -1.75M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 762,363 in cash and 348,345 in debt, with a net cash position of 414,018 or 0.01 per share.
| Cash & Cash Equivalents | 762,363 |
| Total Debt | 348,345 |
| Net Cash | 414,018 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 1.32M |
| Book Value Per Share | 0.02 |
| Working Capital | 486,515 |
Cash Flow
| Operating Cash Flow | -556,037 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2,731 |
| Net Borrowing | 244,966 |
| Free Cash Flow | -556,037 |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 41.36% |
| Operating Margin | -376.10% |
| Pretax Margin | -367.41% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:HEAL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -126.34% |
| Shareholder Yield | -126.34% |
| Earnings Yield | -39.20% |
| FCF Yield | -12.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 24, 2025. It was a reverse split with a ratio of 0.5.
| Last Split Date | Jan 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |